GLG Pharma

GLG Pharma is an organization focused on personalized medicine for oncology using STAT3 inhibitors and a novel cancer culture called Gx-C3. They have obtained worldwide licenses to develop and market pharmaceuticals derived from STAT3 inhibitor technology, which is considered a promising approach to treating various cancers. GLG Pharma has started clinical trials for chronic lymphocytic leukemia a...